Boston, Massachusetts – Nearly 9,000 participants from leading organizations in Europe, North America and other regions of the world convened to share, discuss and advance research in multiple sclerosis (MS) at a meeting managed by Association Management Partners & Executive Directors (AMPED) in September.
AMPED is the association management company for America’s Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS). ACTRIMS hosted the triennial joint meeting with Europe’s Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Boston, Massachusetts. The joint meeting, MSBoston2014, was the largest gathering of its kind for multiple sclerosis researchers and clinicians.
“Our team, led by Marechiel Santos-Lang, did a tremendous job of choreographing the many facets of a meeting of this size,” said Lynda J. Patterson, FASAE, CAE, owner and president of AMPED. “Every step – from choosing the venue to the final accounting – takes careful planning and attention to detail. The ACTRIMS board of directors was very pleased with the success of MSBoston.”
The meeting was a financial success, as well. Sponsorship sales were double the goal set. Net revenue for the event was $4 million.
The next triennial meeting will be hosted by ECTRIMS in Paris, France in 2017.
MSBoston by the numbers
- 8,806 participants from 92 countries
- 59 sessions
- 206 speakers and chairs
- 50 exhibitors
- $10 million revenue
- 981 posters
- 22 late breaking e-posters
- 146 reporters from 22 countries
- 60 original articles
- 85 video and TV interviews
- 1,000+ Tweets reaching 1 million timelines